Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Eikon Therapeutics, Inc. is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs. The Company has clinical programs at various stages of development, and active discovery efforts in oncology and neurologic disease. Its pipeline includes EIK100, EIK1003, EIK1004, EIK1005, EIK1006, and the ARv7 Program. EIK1001 is a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses. EIK1003 and EIK1004 are selective PARP1 inhibitors. These product candidates are designed to inhibit PARP1 while sparing PARP2, thereby promoting tumor regression by targeting the DNA damage response of cancer cells. EIK1005 is designed to inhibit the WRN helicase and is our first internally developed program to advance into clinical studies. EIK1006 is being investigated as a potential next-generation AR antagonist with activity against multiple clinically emergent variants of AR.
Find out what a historical investment in Eikon Therapeutics would be worth today using our EIKN stock calculator.
Buying EIKN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Eikon Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in EIKN
What is the ticker symbol of Eikon Therapeutics?
The ticker symbol for Eikon Therapeutics is EIKN.
How much is one share of EIKN?
One share of EIKN is valued at $4.76 as of 20 November 2026.
What is the market capitalisation of Eikon Therapeutics EIKN?
As of 20 November 2026 Eikon Therapeutics has a market cap of $280.14M.
What is the 52-week high for Eikon Therapeutics stock?
The Eikon Therapeutics 52-week high stock price is $17.40.
What is the 52-week low for Eikon Therapeutics stock?
The Eikon Therapeutics 52-week low stock price is $4.72.
Can I buy EIKN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy EIKN shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in EIKN on Stake
Buy EIKN from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of EIKN from only US$10 with fractional shares